BIOMAT Database Logo BIOMAT Database Logo

Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells. 1979

D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher

UI MeSH Term Description Entries
D007940 Leukemia L5178 An experimental lymphocytic leukemia of mice. Lymphoma L5178,L5178, Leukemia,L5178, Lymphoma
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D009964 Orotidine-5'-Phosphate Decarboxylase Orotidine-5'-phosphate carboxy-lyase. Catalyzes the decarboxylation of orotidylic acid to yield uridylic acid in the final step of the pyrimidine nucleotide biosynthesis pathway. EC 4.1.1.23. Orotidine Phosphate Carboxy-Lyase,Orotidylate Decarboxylase,OMP Decarboxylase,Orotidine 5 Phosphate Decarboxylase,Orotidine 5' Phosphate Decarboxylase,Orotidine-5-Phosphate Decarboxylase,Carboxy-Lyase, Orotidine Phosphate,Decarboxylase, OMP,Decarboxylase, Orotidine-5'-Phosphate,Decarboxylase, Orotidine-5-Phosphate,Decarboxylase, Orotidylate,Orotidine Phosphate Carboxy Lyase,Phosphate Carboxy-Lyase, Orotidine
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002262 Carboxy-Lyases Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1. Carboxy-Lyase,Decarboxylase,Decarboxylases,Carboxy Lyase,Carboxy Lyases
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000248 Adenosine Kinase An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20. Kinase, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)

Related Publications

D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells.
December 1978, Cancer research,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.
September 1977, Cancer research,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
October 1980, Biochimica et biophysica acta,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Growth inhibition of mouse lymphoma cells, L5178Y, in vitro, by glucocorticoids: alterations in choline metabolism.
March 1973, Experimental cell research,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems.
October 1977, Cancer research,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Inhibition of L5178Y cells in culture by methotrexate and antibiotics.
July 1976, Antimicrobial agents and chemotherapy,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Poly (ADP-ribose) metabolism in alkylated mouse L5178Y cells.
July 1985, Carcinogenesis,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Tubercidin metabolism in mouse L5178y cells in vivo and in vitro.
December 1978, Gan,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Metabolism of 1-beta-D-arabinofuranosyluracil in mouse L5178Y cells.
March 1979, Cancer research,
D E Dix, and C P Lehman, and A Jakubowski, and J D Moyer, and R E Handschumacher
Consequences of methotrexate inhibition of purine biosynthesis in L5178Y cells.
June 1975, Cancer research,
Copied contents to your clipboard!